hi Parma
I wonder if this time they will publish a transcript?
I recorded it but the loudest volume at play back is so low as to be very irritating :/
FWIW My notes beyond those on Gascoyne and the Covalent/Mt Holland/Kwinan refinery already mentioned.
•The market should have already factored in the lower cash balance as it was well flagged ($170m worth of equipment bought for Karara alone.
•The dividend: unfranked as no franking credits available (due to NRW accessing ATO’s temporary full expensing allowances)
They don’t expect to pay cash tax until 2024 - better for company and shareholders
Ultimately the upshot will be better for shareholders.
•Jules wanted Greenbushes but Macmahon got it.
(That *wanting* was reaffirmed in a roundabout way a few times in the call by him mentioning NRW had no need to go “chasing tenders to boost revenue.”
Greenbushes would have required $250m capex … it needed to be cost effective for NRW .. and the returns needed to justify the spend, especially after Karara..
further in ;
“… We are very focused on pricing projects correctly” (especially since?) the competitive landscape has lessened -
“Particulaty given the pipeline coming at us”
( but some need to book revenue over margins?)
•He reaffirmed guidance remains as forecast.
Partly due to being conservative? - Queensland having very heavy impact from daily rain which included into first part of this quarter
“January has not been great for Queensland”
Rainfall has made a signifivany impact in regards loss hours
… there and elsewhere delayed projects mean teams have had to be carried longer
… but the weather has improved in February!
I’ll put up the rest later I guess
cheers
- Forums
- ASX - By Stock
- Ann: NRW Half Year Results Announcement
NWH
nrw holdings limited
Add to My Watchlist
1.30%
!
$3.03

hi Parma I wonder if this time they will publish a transcript? I...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.03 |
Change
-0.040(1.30%) |
Mkt cap ! $1.385B |
Open | High | Low | Value | Volume |
$3.09 | $3.09 | $3.00 | $2.566M | 846.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $3.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.06 | 2300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 3.000 |
3 | 6260 | 2.980 |
2 | 1360 | 2.970 |
2 | 15330 | 2.960 |
1 | 1000 | 2.950 |
Price($) | Vol. | No. |
---|---|---|
3.060 | 2300 | 1 |
3.080 | 1000 | 1 |
3.100 | 51017 | 2 |
3.120 | 6395 | 1 |
3.160 | 3400 | 1 |
Last trade - 16.11pm 04/07/2025 (20 minute delay) ? |
Featured News
NWH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online